← FDA DRUG APPROVALS

FDA NDA · NDA009395

PASKALIUM

Sponsor: GLENWOOD

APPLICATION
NDA009395
TYPE
NDA
ORIGINAL APPROVAL
1955-11-18
LATEST ACTION
1955-11-18
ROUTE
ORAL
DOSAGE FORM
TABLET, CAPSULE
MARKETING STATUS
Discontinued

Products

PASKALIUMDiscontinued
POTASSIUM AMINOSALICYLATE 1GM · TABLET · ORAL
PASKALIUMDiscontinued
POTASSIUM AMINOSALICYLATE 500MG · CAPSULE · ORAL

Approval history

1955-11-18Type 2 - New Active Ingredient · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →